(VIANEWS) – The NASDAQ opens in less than two hours and Tilray‘s pre-market value is already 4.84% up.
Tilray’s last close was $1.86, 64.02% under its 52-week high of $5.17.
The last session, NASDAQ ended with Tilray (TLRY) dropping 21.19% to $1.86. NASDAQ rose 2.19% to $12,975.69, after two sequential sessions in a row of gains, on what was an all-around positive trend trading session.
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Earnings Per Share
As for profitability, Tilray has a trailing twelve months EPS of $-2.99.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -44.15%.
Today’s last reported volume for Tilray is 51347205 which is 228.93% above its average volume of 10703000.
Tilray’s sales growth for the next quarter is 4.7%.
Tilray’s worth is way under its 50-day moving average of $2.50 and way below its 200-day moving average of $3.16.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Tilray’s EBITDA is 2.87.
More news about Tilray (TLRY).